000 01295 a2200349 4500
005 20250518050806.0
264 0 _c20200930
008 202009s 0 0 eng d
022 _a2284-0729
024 7 _a10.26355/eurrev_201907_18347
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aJin, H
245 0 0 _aNew findings of heparanase in human diseases.
_h[electronic resource]
260 _bEuropean review for medical and pharmacological sciences
_cJul 2019
300 _a5999-6004 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aDisease
650 0 4 _aEnzyme Inhibitors
_xchemistry
650 0 4 _aEpithelial-Mesenchymal Transition
_xdrug effects
650 0 4 _aGlucuronidase
_xantagonists & inhibitors
650 0 4 _aHumans
650 0 4 _aInflammation
_xdrug therapy
650 0 4 _aKidney Diseases
_xdrug therapy
650 0 4 _aLiver Cirrhosis
_xdrug therapy
650 0 4 _aNeoplasms
_xdrug therapy
650 0 4 _aNervous System Diseases
_xdrug therapy
650 0 4 _aVirus Diseases
_xdrug therapy
700 1 _aCui, M
700 1 _aHu, S-X
773 0 _tEuropean review for medical and pharmacological sciences
_gvol. 23
_gno. 13
_gp. 5999-6004
856 4 0 _uhttps://doi.org/10.26355/eurrev_201907_18347
_zAvailable from publisher's website
999 _c29894058
_d29894058